RACGP response to ACCC review of the merger between Australian Clinical Labs Limited and Healius Limited

  1. 74 Posts.
    lightbulb Created with Sketch. 7
    RACGP is an influential group and this response likely to have some weight.

    https://www.racgp.org.au/advocacy/reports-and-submissions/view-all-reports-and-submissions/2023-reports-and-submissions/racgp-response-to-accc-review-of-the-merger

    HomeAdvocacyReports andsubmissionsView allreports and submissions2023 reports andsubmissionsRACGPresponse to ACCC review of the merger between Australian Clinical Labs Limitedand Healius Lim

    Date: 29 May2023

    The RACGP hasresponded to the Australian Competition and Consumer Commission (ACCC) reviewof the merger between Australian Clinical Labs Limited (ACL) and HealiusLimited (Healius). The RACGP letter highlights the potential impacts of thismerger on access to healthcare for patients across Australia.

    Readthe submission.Letter to ACCC re Pathology Merger- 29 May 2023 (PDF)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
79.3¢
Change
-0.023(2.76%)
Mkt cap ! $577.2M
Open High Low Value Volume
81.0¢ 82.5¢ 78.8¢ $2.092M 2.604M

Buyers (Bids)

No. Vol. Price($)
29 90522 79.0¢
 

Sellers (Offers)

Price($) Vol. No.
79.5¢ 63499 32
View Market Depth
Last trade - 12.55pm 13/08/2025 (20 minute delay) ?
HLS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.